Global pharmaceutical sales up 5 percent: IMS Health

Share this article:
Global pharmaceutical sales grew 5 percent in the 12 months to August in leading markets, IMS Health said this week.
Sales through retail pharmacies in 13 leading markets, which account for more than two-thirds of the world market, totaled $364 billion in the period.
The single largest drug class was cholesterol-lowering medicines, which sold $27.8 billion and showed a growth rate of 8.2 percent, a slight decrease, from the previous 12-month period.
Pfizer's Lipitor cholesterol pill remained the world's best-selling drug, with global sales of $11.2 billion, followed by Merck's Zocor, AstraZeneca's Nexium, Sanofi-Aventis and Bristol-Myers Squibb's Plavix, and GlaxoSmithKline's Advair/Seretide.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.